Evidence map›Paper›PMID 41799759›Full record

ArticleInternational journal of medical sciences2026

Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma.

Wei Lu, Susu Jiang, Qiran Sun, Yating Huang, Ying Yang, Xiaoqin Wang, Liwen Zhang, Yi Guo, Rujun Chen

Abstract read
In one paragraph

Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei LuDepartment of Gynecology and Obstetrics, Shanghai East Hospital, Tongji University, Shanghai, China.
Susu JiangDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Qiran SunDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Yating HuangDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Ying YangDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Xiaoqin WangDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Liwen ZhangDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Yi GuoDepartment of Gynecology and Obstetrics, Shanghai East Hospital, Tongji University, Shanghai, China.
Rujun ChenDepartment of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Uterine leiomyosarcoma (ULMS) is a rare, aggressive uterine malignancy with high misdiagnosis rates, poor prognosis, and limited molecular biomarkers. Its pathogenesis, links between specific genes and the tumor immune microenvironment (TIME), and applications of machine learning (ML) and Mendelian randomization (MR) remain understudied. Methods: Multi-cohort data (4 GEO datasets, TCGA-SARC, single-cell sequencing) were integrated. Differentially expressed genes (DEGs) and WGCNA-derived key modules identified "InteGenes". 113 ML algorithms were compared to build a diagnostic model (top: GBM, core genes = "Mgenes"). CIBERSORT analyzed TIME; MR explored Mgenes-ULMS causal links. Results: 96 InteGenes enriched in cell cycle/p53/DNA repair pathways. The GBM model had training AUC = 1 and validation accuracy 92.3-100%; 36 Mgenes (e.g., TRIP13, AUC = 0.972) showed diagnostic value. Mgenes correlated with TIME (upregulated Mgenes ↔ M2 TAMs/Tregs; downregulated ↔ effector cells). MR found no genetic causality between Mgenes and ULMS. Conclusion: InteGenes reflect ULMS pathogenesis; the GBM model and Mgenes are promising diagnostic tools. Mgenes modulate ULMS's TIME, offering immunotherapeutic targets. This study advances ULMS molecular/immune understanding for translational research.

Indexed as

Biomarkers, TumorLeiomyosarcomaMachine LearningUterine NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMultiomicsPrognosisTumor MicroenvironmentBiomarkers, Tumordiagnostic modelmachine learningsingle-cell sequencingtumor immune microenvironmentuterine leiomyosarcoma

Identifiers

PMID41799759
PMCPMC12964573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.